“Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver” (2024) Medical Forum Monthly, 28(12). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/4304 (Accessed: 16 April 2026).